The order carried out as a part of the project titled:
IBD – Preclinical research and Clinical Trials of a first-in-class development candidate in therapy of for Asthma and Inflammatory Bowel Disease (POIR.01.01.01 00-0168/15)
co-financed by the European Union Funds and because of the competitiveness principle.
We hereby look for Contractor ready to provide:
In vivo study of chitinase inhibitor efficacy in the rat model of inflammatory bowel disease (IBD) induced with 2,4,6-trinitrobenzenesulfonic acid (TNBS), in which there is observable granulomas formation